These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 15355330
1. Metabotropic glutamate receptor 5 localized in the limbic forebrain is critical for the development of morphine-induced rewarding effect in mice. Aoki T, Narita M, Shibasaki M, Suzuki T. Eur J Neurosci; 2004 Sep; 20(6):1633-8. PubMed ID: 15355330 [Abstract] [Full Text] [Related]
2. Effects of CNQX and MPEP on sensitization to the rewarding effects of morphine. Manzanedo C, Aguilar MA, Miñarro J, Rodríguez-Arias M. Eur J Pharmacol; 2011 Mar 01; 654(1):42-6. PubMed ID: 21172339 [Abstract] [Full Text] [Related]
3. The mGluR5 antagonist MPEP reduces the conditioned rewarding effects of cocaine but not other drugs of abuse. McGeehan AJ, Olive MF. Synapse; 2003 Mar 01; 47(3):240-2. PubMed ID: 12494407 [Abstract] [Full Text] [Related]
4. Implication of mGlu5 receptor in the enhancement of morphine-induced hyperlocomotion under chronic treatment with zolpidem. Shibasaki M, Ishii K, Masukawa D, Ando K, Ikekubo Y, Ishikawa Y, Shibasaki Y, Mori T, Suzuki T. Eur J Pharmacol; 2014 Sep 05; 738():360-7. PubMed ID: 24930812 [Abstract] [Full Text] [Related]
5. Effects of MPEP on locomotion, sensitization and conditioned reward induced by cocaine or morphine. Herzig V, Schmidt WJ. Neuropharmacology; 2004 Dec 05; 47(7):973-84. PubMed ID: 15555632 [Abstract] [Full Text] [Related]
6. Morphine conditioned reward is inhibited by MPEP, the mGluR5 antagonist. Popik P, Wróbel M. Neuropharmacology; 2002 Dec 05; 43(8):1210-7. PubMed ID: 12527470 [Abstract] [Full Text] [Related]
11. Direct evidence for the involvement of the mesolimbic kappa-opioid system in the morphine-induced rewarding effect under an inflammatory pain-like state. Narita M, Kishimoto Y, Ise Y, Yajima Y, Misawa K, Suzuki T. Neuropsychopharmacology; 2005 Jan 05; 30(1):111-8. PubMed ID: 15257306 [Abstract] [Full Text] [Related]
13. Interactive effects of the mGlu5 receptor antagonist MPEP and the mGlu2/3 receptor antagonist LY341495 on nicotine self-administration and reward deficits associated with nicotine withdrawal in rats. Liechti ME, Markou A. Eur J Pharmacol; 2007 Jan 12; 554(2-3):164-74. PubMed ID: 17113075 [Abstract] [Full Text] [Related]
17. Inhibitory effects of MPEP, an mGluR5 antagonist, and memantine, an N-methyl-D-aspartate receptor antagonist, on morphine antinociceptive tolerance in mice. Kozela E, Pilc A, Popik P. Psychopharmacology (Berl); 2003 Jan 12; 165(3):245-51. PubMed ID: 12442203 [Abstract] [Full Text] [Related]
19. Functional Interaction Between NMDA and mGlu5 Receptors: Effects on Working Memory, Instrumental Learning, Motor Behaviors, and Dopamine Release. Homayoun H, Stefani MR, Adams BW, Tamagan GD, Moghaddam B. Neuropsychopharmacology; 2004 Jul 12; 29(7):1259-69. PubMed ID: 15010696 [Abstract] [Full Text] [Related]
20. Effect of MS-153, a glutamate transporter activator, on the conditioned rewarding effects of morphine, methamphetamine and cocaine in mice. Nakagawa T, Fujio M, Ozawa T, Minami M, Satoh M. Behav Brain Res; 2005 Jan 30; 156(2):233-9. PubMed ID: 15582109 [Abstract] [Full Text] [Related] Page: [Next] [New Search]